Clicky

Next Science Ltd(NXSCF)

Description: Next Science Limited, a medical technology company, develops and commercializes non-toxic technology products with efficacy in eradicating biofilm based and free-floating bacteria. The company develops its products using its Xbio Technology platform. It offers SurgX, an innovative surgical gel designed to reduce superficial surgical site infections and protect wound tissue to facilitate natural healing; and Bactisure, a surgical lavage that is used to remove debris, including microorganisms from wounds. The company also provides TorrentX, an antimicrobial wound wash; and BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment. In addition, it is developing acne gel; middle ear wash for use in patients with chronic ear infections; minimally invasive surgical lavage to replace a saline wound lavage; nasal packing stent for use in recovery from nasal surgery; adhesion barrier that is implanted in surgery field to prevent internal adhesion; and soft coating for implants. Further, the company develops tropical treatments for school sores, infected atopic dermatitis, and fungal nails; tropical preventative treatment for keloid scarring; and products for bacterial vaginosis, as well as over the counter products, such as mouthwash. Next Science Limited was founded in 2012 and is headquartered in Sydney, Australia.


Keywords: Medicine Clinical Medicine Surgery Medical Technology Organisms Atopic Dermatitis Dermatitis Antimicrobial Scar Healing Over The Counter Products Nail Biofilm Counter Products Microorganism Mouthwash Bacterial Vaginosis Bio Technology Adhesion Nails Surgical Site Infections Adhesion Barrier Keloid Saline Superficial Surgical Site Infections

Home Page: www.nextscience.com

The Zenith Building, Tower A
Chatswood, NSW 2067
Australia
Phone: 61 2 8607 5126


Officers

Name Title
Ms. Judith Mitchell M.B.A. MD, CEO & Exec. Director
Dr. Matthew Franco Myntti Founder & CTO
Ms. Jacqueline Butler CA (ICAEW) Chief Financial Officer
Mr. Jon Swanson Chief Operating Officer
Mr. Michael Morello VP of Sales
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD Company Sec.

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 9.1659
Trailing PE: 0
Price-to-Book MRQ: 7.2159
Price-to-Sales TTM: 9.2052
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks